Innovation

Ex vivo Porcine Eye Toxicity Test for Consumer Products

Wayne State University
posted on 01/27/2012

Ex vivo Porcine Eye Toxicity Test for Consumer Products

 

Case ID:

11-1008

Description:

Fu-Shin Yu Ph.D., Keping Xu M.D.

Departments of Ophthalmology and Anatomy & Cell Biology

 

School of Medicine @ Wayne State University

 

Background:

Wayne State researchers have devised an ex vivo test for measuring the toxicity of chemicals in the eye. It is based on organ cultured of porcine eyes in a defined in vitro environment. Outputs from the test allow for identification of the degree of toxicity to the eye for chemical testing. The test is an improvement over the Draize eye irritation test that has been used for over fifty years assessing the safety of commercial products. The approach entails a proprietary process of preparing and wounding porcine corneas, introducing the foreign amount and measuring the amount of healing rate as an end point of toxicity.

Competitive Advantage:

·         Test indicate reduced variability, improved cycle time, and reduction in cost from the traditional Draize test

·         The corneas (representing 75% of the Draize score) are the targeted organs

·         Utilizes fresh eyes from slaughterhouses, as such method is economical and easily standardized

Commercial Applications:

Possible commercial uses include:

·         To assess the irritancy and toxicity of commercial products including drugs, cosmetics, home and automobile care products, or bulk chemicals

·         Application in assisting cosmetics, skin care, and eye care firms to screen compounds for potential toxicity in the product development process

·         To predict if a chemical, solvent, or combination of substances can be used to make cosmetics

·         Useful in research environments where animal testing is discouraged or banned (e.g. Europe)

Publication(s):

 

Publication link:               

 

If you are interested in learning more about this patented technology please contact:

Andrew M. Olson, M.B.A.

Technology Commercialization Office @ Wayne State University

(313) 874-5619

Andrew.Olson@wayne.edu

]]>


Innovation Details
 

File Number: 11-1008 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Andrew Olson at Wayne State University for more information.

Request more info via email request more info
People

Case Manager:

Andrew Olson Andrew Olson

Innovations (20)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,815 members 16,688 innovations 159 organizations

Browse

Linda L. Restifo, M.D., Ph.D. - University of Arizona

"I want to say again how happy I am about the iBridge Network mechanism. This seems ideal for NeuronMetrics and I'm very pleased we will be part of this venture."  read more...